Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
HuidaGenehuidagene.com · Low evidenceHuidaGene is a biotechnology company developing gene therapies for ophthalmology, neurology, and neuromuscular diseases. Its pipeline includes treatments for conditions such as RPE65-associated inherited retinal dystrophies, Huntington's disease, and Duchenne muscular dystrophy.
Parse Score